Abnormalities in colonic glycoprotein synthesis have been implicated in the pathogenesis of ulcerative colitis and Crohn's disease. Glucosamine synthetase is the rate-limiting step in the biosynthesis of gastrointestinal glycoprotein and has been measured in control subjects (N = 23) and patients with ulcerative colitis (N = 26) or Crohn's disease of the colon (N = 20) classified according to the macroscopic status of the rectum. Glucosamine synthetase activity was relatively constant around the normal colon but lower levels were found in the terminal ileum. In ulcerative colitis, glucosamine synthetase activity was similar to controls (24.0 +/- 1.9) mmol/g wet (wt/hr) irrespective of disease activity (quiescent: N = 13, = 27.3 +/- 1.9; active N = 16, = 26.2 +/- 2.3). Rectal glucosamine synthetase activity was normal in the presence of active Crohn's proctocolitis (29.4 +/- 3.1) but raised in patients with Crohn's colitis and rectal sparing (37.2 +/- 4.9 P < 0.02). Glucosamine synthetase activity was strongly influence by the degree of epithelial preservation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02088339 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
and : Potential Therapeutic Targets for Gastric Cancer.
Discov Med
December 2024
Department of Oncology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, 213003 Changzhou, Jiangsu, China.
Background: Detecting and treating stomach cancer requires a comprehensive understanding of how gastric cancer develops and progresses. In this context, efforts have been made to elucidate the regulation of glutamine-fructose-6-phosphate transaminase 1 () and Lysine demethylase 4C () in gastric cancer.
Methods: Bioinformatics was utilized to predict the levels and correlation of and in gastric cancer, followed by determining their expressions via quantitative real-time polymerase chain reaction (qRT-PCR).
Sugar phosphate-mediated inhibition of peptidoglycan precursor synthesis.
bioRxiv
November 2024
Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA.
Antibiotic tolerance, the widespread ability of diverse pathogenic bacteria to sustain viability in the presence of typically bactericidal antibiotics for extended time periods, is an understudied steppingstone towards antibiotic resistance. The Gram-negative pathogen , the causative agent of cholera, is highly tolerant to β-lactam antibiotics. We previously found that the disruption of glycolysis, via deletion of (, glucose-6-phosphate isomerase), resulted in significant cell wall damage and increased sensitivity towards β-lactam antibiotics.
View Article and Find Full Text PDFA Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ).
Biomolecules
October 2024
Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.
The neuromuscular junction (NMJ) is the site where the motor neuron innervates skeletal muscle, enabling muscular contraction. Congenital myasthenic syndromes (CMS) arise when mutations in any of the approximately 35 known causative genes cause impaired neuromuscular transmission at the NMJ, resulting in fatigable muscle weakness. A subset of five of these CMS-causative genes are associated with protein glycosylation.
View Article and Find Full Text PDFEnhancing GFPT1 expression with glutamine protects chondrocytes in osteoarthritis.
Int Immunopharmacol
December 2024
Department of Orthopaedic Surgery, Orthopaedic Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, People's Republic of China. Electronic address:
Objective: Osteoarthritis (OA) is the leading joint disease without currently available disease-modified drugs. The current study aimed to identify potential drug targets that could decelerate the progression of OA.
Methods: We employed Mendelian Randomization (MR) and colocalization analysis to identify therapeutic targets linked to 12 OA traits within 2645 targets.
GFPT2: A novel biomarker in mesothelioma for diagnosis and prognosis and its molecular mechanism in malignant progression.
Br J Cancer
November 2024
Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Article Synopsis
- Mesothelioma (MESO) is a challenging cancer with poor outcomes, and the study identifies GFPT2 as a key biomarker for diagnosing and predicting its progression.
- Using various methods, including tissue samples and advanced lab techniques, the research highlights GFPT2's significant role in enhancing MESO's malignancy and its potential in driving aggressive cancer behavior.
- The findings position GFPT2 as not only a vital diagnostic tool for MESO but also a promising target for new treatment approaches, potentially improving management strategies for this disease.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!